Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
CANC

Price
37.34
Stock movement up
+0.37 (1.00%)
Company name
Tema Oncology ETF
Exchange
(NASDAQ
,
Currency
USD
)
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
0.05%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
48.39%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share0.02
Dividend yield0.05%
Payout frequencyAnnual
Maximum yield3.47%
Average yield2.61%
Minimum yield0.05%
Discount to avg yield-4769.90%
Upside potential-97.95%
Yield as % of max yield1.54%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield0.05%
Current yield distribution99.69%
Yield at 100% (Min)0.05%
Yield at 90%2.10%
Yield at 80%2.42%
Yield at 50% (Median)2.77%
Yield at 20%2.94%
Yield at 10%3.01%
Yield at 0% (Max)3.47%

Dividend per share

Loading...
Dividend per share data
Years of growth-
CCC status-
Dividend per share0.02
Payout frequencyAnnual
Ex-div date10 Dec 2025
EPS (TTM)-
EPS (1y forward)-
EPS growth (5y)-
EPS growth (5y forward)-

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
CANCS&P500
DGR MR-97.25%-13.74%
DGR TTM-97.25%6.60%
DGR 3 years-7.31%
DGR 5 years-4.69%
DGR 10 years-6.30%
DGR 15 years-8.16%
Time since last change announced56 days
EPS growth (5y)-
EPS growth (5y forward)-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open37.21
Daily high37.51
Daily low37.03
Daily Volume50K
All-time high37.34
1y analyst estimate-
Beta-
EPS (TTM)-
Dividend per share0.02
Ex-div date10 Dec 2025
Next earnings date-

Downside potential

Loading...
Downside potential data
CANCS&P500
Current price drop from All-time high-0.30%-1.40%
Highest price drop-29.97%-19.00%
Date of highest drop8 Apr 20258 Apr 2025
Avg drop from high-11.17%-2.49%
Avg time to new high15 days6 days
Max time to new high250 days89 days
COMPANY DETAILS
CANC (Tema Oncology ETF) company logo
Marketcap
-
Marketcap category
Mid-cap
Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Employees
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner